Hormone Receptor Positive HER-2 Negative Breast Cancer trials recruiting in Ohio

Fewer than 3 recruiting trials found.

All Hormone Receptor Positive HER-2 Negative Breast Cancer trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
  NCT06369285 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus, Maumee
• BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
  NCT06120283 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus